MelaMedic ApS: Financial statements 2024
CVR: 40641947
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
MelaMedic ApS (CVR 40641947) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 153,523 and a net result of DKK 98,819 compared with DKK -235,597 the year before. Equity in the 2024 report amounted to DKK 317,791. The solvency ratio was 83%.
- Gross Profit
- DKK 153,523
- Profit/Loss
- DKK 98,819
- Equity
- DKK 317,791
- Total Assets
- DKK 382,825
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 154 t. | 99 t. | 318 t. | - |
| 2023 | - | 0 | -236 t. | 219 t. | - |
| 2021 | - | 560 t. | 226 t. | 417 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout MelaMedic ApS
MelaMedic ApS is a Danish company of the type Anpartsselskab based in Aars, founded in 2019. The company is registered under the industry Detailhandel med andre nye varer. The management consists of Lars Bjørn. The company is owned by Lars Bjørn. In 2025, the company reported a gross profit of DKK 443,298 and a net result of DKK 50,375 compared with DKK 98,819 the year before. Equity in the 2025 report amounted to DKK 368,166.